The use of dendritic cell vaccinations in melanoma: where are we now?
Melanoma Manag
.
2016 Dec;3(4):247-250.
doi: 10.2217/mmt-2016-0027.
Epub 2016 Nov 29.
Authors
Altuna Halilovic
1
2
1
2
,
Kalijn F Bol
1
3
1
3
Affiliations
1
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
2
Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
3
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
PMID:
30190894
PMCID:
PMC6094693
DOI:
10.2217/mmt-2016-0027
No abstract available
Keywords:
dendritic cell vaccine; immunotherapy; melanoma.
Publication types
Editorial